Cited by 16Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

Sex-specific transcriptional rewiring in the brain of Alzheimer’s disease patients

Open access
Santiago, Jose A., Quinn, James P., Potashkin, Judith A.·2022·Frontiers in Aging Neuroscience

Abstract

Sex-specific differences may contribute to Alzheimer's disease (AD) development. AD is more prevalent in women worldwide, and female sex has been suggested as a disease risk factor. Nevertheless, the molecular mechanisms underlying sex-biased differences in AD remain poorly characterized. To this end, we analyzed the transcriptional changes in the entorhinal cortex of symptomatic and asymptomatic AD patients stratified by sex. Co-expression network analysis implemented by SWItchMiner software identified sex-specific signatures of switch genes responsible for drastic transcriptional changes in the brain of AD and asymptomatic AD individuals. Pathway analysis of the switch genes revealed that morphine addiction, retrograde endocannabinoid signaling, and autophagy are associated with both females with AD (F-AD) and males with (M-AD). In contrast, nicotine addiction, cell adhesion molecules, oxytocin signaling, adipocytokine signaling, prolactin signaling, and alcoholism are uniquely associated with M-AD. Similarly, some of the unique pathways associated with F-AD switch genes are viral myocarditis, Hippo signaling pathway, endometrial cancer, insulin signaling, and PI3K-AKT signaling. Together these results reveal that there are many sex-specific pathways that may lead to AD. Approximately 20-30% of the elderly have an accumulation of amyloid beta in the brain, but show no cognitive deficit. Asymptomatic females (F-asymAD) and males (M-asymAD) both shared dysregulation of endocytosis. In contrast, pathways uniquely associated with F-asymAD switch genes are insulin secretion, progesterone-mediated oocyte maturation, axon guidance, renal cell carcinoma, and ErbB signaling pathway. Similarly, pathways uniquely associated with M-asymAD switch genes are fluid shear stress and atherosclerosis, FcγR mediated phagocytosis, and proteoglycans in cancer. These results reveal for the first time unique pathways associated with either disease progression or cognitive resilience in asymptomatic individuals. Additionally, we identified numerous sex-specific transcription factors and potential neurotoxic chemicals that may be involved in the pathogenesis of AD. Together these results reveal likely molecular drivers of sex differences in the brain of AD patients. Future molecular studies dissecting the functional role of these switch genes in driving sex differences in AD are warranted.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnagi.2022.1009368

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 143 · Cited by 16

Research works printed but not linked: 129

  1. Aggarwal N. T. Bienias J. L. Bennett D. A. Wilson R. S. Morris M. C. Schneider J. A.. (2006). The relation of cigarette smoking to incident Alzheimer's disease in a biracial urban community population. Neuroepidemiology 26, 140– 146. doi: 10.1159/000091654, PMID: 16493200 · DOI
  2. Arora D. K. Syed I. Machhadieh B. McKenna C. E. Kowluru A. (2012). Rab-geranylgeranyl transferase regulates glucose-stimulated insulin secretion from pancreatic beta cells. Islets 4, 354– 358. doi: 10.4161/isl.22538, PMID: 23114750 PMC3524143 · DOI
  3. Athauda D. Maclagan K. Budnik N. Zampedri L. Hibbert S. Aviles-Olmos I.. (2019). Post hoc analysis of the Exenatide-PD trial-factors that predict response. Eur. J. Neurosci. 49, 410– 421. doi: 10.1111/ejn.14096, PMID: 30070753 · DOI
  4. Bachman D. L. Wolf P. A. Linn R. T. Knoefel J. E. Cobb J. L. Belanger A. J.. (1993). Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham study. Neurology 43, 515– 519. doi: 10.1212/wnl.43.3_part_1.515 8450993 · DOI · Paper page
  5. Bai J. D. K. Babu S. Roa-Pena L. Hou W. Akalin A. Escobar-Hoyos L. F.. (2019). Keratin 17 is a negative prognostic biomarker in high-grade endometrial carcinomas. Hum. Pathol. 94, 40– 50. doi: 10.1016/j.humpath.2019.09.005, PMID: 31655172 · DOI
  6. Bell S. J. Laitinen M. L. Lavikainen P. Lonnroos E. Uosukainen H. Hartikainen S. (2011). Use of strong opioids among community-dwelling persons with and without Alzheimer's disease in Finland. Pain 152, 543– 547. doi: 10.1016/j.pain.2010.11.003, PMID: 21247697 · DOI
  7. Belonwu S. A. Li Y. Bunis D. Rao A. A. Solsberg C. W. Tang A.. (2022). Sex-stratified single-cell RNA-Seq analysis identifies sex-specific and cell type-specific transcriptional responses in Alzheimer's disease across two brain regions. Mol. Neurobiol. 59, 276– 293. doi: 10.1007/s12035-021-02591-8, PMID: 34669146 PMC8786804 · DOI
  8. Berisha S. Z. Serre D. Schauer P. Kashyap S. R. Smith J. D. (2011). Changes in whole blood gene expression in obese subjects with type 2 diabetes following bariatric surgery: a pilot study. PLoS One 6: e16729. doi: 10.1371/journal.pone.0016729, PMID: 21423737 PMC3053356 · DOI
  9. Bone R. N. Oyebamiji O. Talware S. Selvaraj S. Krishnan P. Syed F.. (2020). A computational approach for defining a signature of beta-cell Golgi stress in diabetes. Diabetes 69, 2364– 2376. doi: 10.2337/db20-0636, PMID: 32820009 PMC7576569 · DOI
  10. Bottero V. Powers D. Yalamanchi A. Quinn J. P. Potashkin J. A. (2021). Key disease mechanisms linked to Alzheimer's disease in the entorhinal cortex. Int. J. Mol. Sci. 22: 3915. doi: 10.3390/ijms22083915, PMID: 33920138 PMC8069371 · DOI
  11. Bottero V. Santiago J. A. Quinn J. P. Potashkin J. A. (2022). Key disease mechanisms linked to amyotrophic lateral sclerosis in spinal cord motor neurons. Front. Mol. Neurosci. 15: 825031. doi: 10.3389/fnmol.2022.825031, PMID: 35370543 PMC8965442 · DOI
  12. Brenner D. E. Kukull W. A. van Belle G. Bowen J. D. McCormick W. C. Teri L.. (1993). Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology 43, 293– 300. doi: 10.1212/wnl.43.2.293, PMID: 8437692 · DOI
  13. Calio M. L. Mosini A. C. Marinho D. S. Salles G. N. Massinhani F. H. Ko G. M.. (2021). Leptin enhances adult neurogenesis and reduces pathological features in a transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 148: 105219. doi: 10.1016/j.nbd.2020.105219, PMID: 33301880 · DOI
  14. Carretero J. Sanchez-Robledo V. Carretero-Hernandez M. Catalano-Iniesta L. Garcia-Barrado M. J. Iglesias-Osma M. C.. (2019). Prolactin system in the hippocampus. Cell Tissue Res. 375, 193– 199. doi: 10.1007/s00441-018-2858-2, PMID: 29806058 · DOI
  15. Chen W. Ge Y. Lu J. Melo J. So Y. W. Juneja R.. (2022). Distinct functional alterations and therapeutic options of two pathological De novo variants of the T292 residue of GABRA1 identified in children with epileptic encephalopathy and neurodevelopmental disorders. Int. J. Mol. Sci. 23. doi: 10.3390/ijms23052723, PMID: 35269865 PMC8911174 · DOI
  16. Chen W. Y. Liu S. Y. Chang Y. S. Yin J. J. Yeh H. L. Mouhieddine T. H.. (2015). MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer. Oncotarget 6, 441– 457. doi: 10.18632/oncotarget.2690, PMID: 25436980 PMC4381606 · DOI
  17. Chen H. J. Yan X. Y. Sun A. Zhang L. Zhang J. Yan Y. E. (2022). High-fat-diet-induced extracellular matrix deposition regulates integrin-FAK signals in adipose tissue to promote obesity. Mol. Nutr. Food Res. 66: e2101088. doi: 10.1002/mnfr.202101088, PMID: 35106921 · DOI
  18. Choi D. Lee G. Kim K. H. Bae H. (2022). Particulate matter exacerbates the death of dopaminergic neurons in Parkinson's disease through an inflammatory response. Int. J. Mol. Sci. 23: 6487. doi: 10.3390/ijms23126487, PMID: 35742931 PMC9223534 · DOI
  19. Costanza M. Pedotti R. (2016). Prolactin: friend or foe in central nervous system autoimmune inflammation? Int. J. Mol. Sci. 17: 2026. doi: 10.3390/ijms17122026, PMID: 27918427 PMC5187826 · DOI
  20. Cui J. Wang Y. Dong Q. Wu S. Xiao X. Hu J.. (2011). Morphine protects against intracellular amyloid toxicity by inducing estradiol release and upregulation of Hsp70. J. Neurosci. 31, 16227– 16240. doi: 10.1523/JNEUROSCI.3915-11.2011, PMID: 22072674 PMC6633253 · DOI
  21. Dakik L. Basbous M. Tamim H. Moubarak Y. Tarek N. Hamideh D.. (2022). Vincristine-induced neurotoxicity in pediatric patients with rhabdomyosarcoma: a retrospective analysis of clinical features and outcome. Pediatr. Hematol. Oncol. 39, 644– 649. doi: 10.1080/08880018.2022.2047849, PMID: 35262458 · DOI
  22. Davis E. J. Solsberg C. W. White C. C. Minones-Moyano E. Sirota M. Chibnik L.. (2021). Sex-specific Association of the X Chromosome with Cognitive Change and tau Pathology in aging and Alzheimer’s disease. JAMA Neurol. 78, 1249– 1254. doi: 10.1001/jamaneurol.2021.2806, PMID: 34424272 PMC8383157 · DOI
  23. Di Carlo A. Baldereschi M. Amaducci L. Lepore V. Bracco L. Maggi S.. (2002). Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA study. J. Am. Geriatr. Soc. 50, 41– 48. doi: 10.1046/j.1532-5415.2002.50006.x, PMID: 12028245 · DOI
  24. Di Fiore R. Suleiman S. Drago-Ferrante R. Subbannayya Y. Pentimalli F. Giordano A.. (2022). Cancer stem cells and their possible implications in cervical cancer: a short review. Int. J. Mol. Sci. 23: 5167. doi: 10.3390/ijms23095167, PMID: 35563557 PMC9106065 · DOI
  25. Digma L. A. Madsen J. R. Rissman R. A. Jacobs D. M. Brewer J. B. Banks S. J. (2020). Women can bear a bigger burden: ante-and post-mortem evidence for reserve in the face of tau. Brain Com. 2: fcaa025. doi: 10.1093/braincomms/fcaa025, PMID: 32337508 PMC7166251 · DOI
  26. DuBois J. C. Ray A. K. Gruber R. C. Zhang Y. Aflakpui R. Macian-Juan F.. (2019). Akt3-mediated protection against inflammatory demyelinating disease. Front. Immunol. 10: 1738. doi: 10.3389/fimmu.2019.01738, PMID: 31404142 PMC6669559 · DOI
  27. Duc Nguyen H. Pal Y. Hoang N. H. M. Jo W. H. Young Chung H. Kim M. S. (2022). Prolactin and its altered action in Alzheimer's disease and Parkinson's disease. Neuroendocrinology 112, 427– 445. doi: 10.1159/000517798, PMID: 34126620 · DOI
  28. Eissman J. M. Dumitrescu L. Mahoney E. R. Smith A. N. Mukherjee S. Lee M. L.. (2022). Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease. Brain 145, 2541– 2554. doi: 10.1093/brain/awac177, PMID: 35552371 PMC9337804 · DOI
  29. El-Ganainy S. O. Soliman O. A. Ghazy A. A. Allam M. Elbahnasi A. I. Mansour A. M.. (2022). Intranasal oxytocin attenuates cognitive impairment, beta-amyloid burden and tau deposition in female rats with Alzheimer's disease: interplay of ERK1/2/GSK3beta/Caspase-3. Neurochem. Res. 47, 2345– 2356. doi: 10.1007/s11064-022-03624-x, PMID: 35596040 PMC9352611 · DOI
  30. Falcone R. Conte F. Fiscon G. Pecce V. Sponziello M. Durante C.. (2019). BRAF(V600E)-mutant cancers display a variety of networks by SWIM analysis: prediction of vemurafenib clinical response. Endocrine 64, 406– 413. doi: 10.1007/s12020-019-01890-4, PMID: 30850937 · DOI
  31. Fiscon G. Conte F. Farina L. Paci P. (2018a). Network-based approaches to explore complex biological systems towards network medicine. Genes 9. doi: 10.3390/genes9090437, PMID: 30200360 PMC6162385 · DOI
  32. Fiscon G. Conte F. Licursi V. Nasi S. Paci P. (2018b). Publisher correction: computational identification of specific genes for glioblastoma stem-like cells identity. Sci. Rep. 8: 10593. doi: 10.1038/s41598-018-28287-z, PMID: 29985389 PMC6037759 · DOI
  33. Fiscon G. Conte F. Paci P. (2018c). SWIM tool application to expression data of glioblastoma stem-like cell lines, corresponding primary tumors and conventional glioma cell lines. BMC Bioinformatics 19: 436. doi: 10.1186/s12859-018-2421-x, PMID: 30497369 PMC6266956 · DOI
  34. Fisher D. W. Bennett D. A. Dong H. (2018). Sexual dimorphism in predisposition to Alzheimer's disease. Neurobiol. Aging 70, 308– 324. doi: 10.1016/j.neurobiolaging.2018.04.004, PMID: 29754747 PMC6368179 · DOI · Paper page
  35. Fratiglioni L. Viitanen M. von Strauss E. Tontodonati V. Herlitz A. Winblad B. (1997). Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen project. Stockholm. Neurol. 48, 132– 138. doi: 10.1212/wnl.48.1.132, PMID: 9008508 · DOI · Paper page
  36. Ge B. H. Li G. C. (2020). Long non-coding RNA SNHG17 promotes proliferation, migration and invasion of glioma cells by regulating the miR-23b-3p/ZHX1 axis. J. Gene Med. 22: e3247. doi: 10.1002/jgm.3247, PMID: 32602607 · DOI
  37. Griffin E. A. Jr. Melas P. A. Zhou R. Li Y. Mercado P. Kempadoo K. A.. (2017). Prior alcohol use enhances vulnerability to compulsive cocaine self-administration by promoting degradation of HDAC4 and HDAC5. Sci. Adv. 3: e1701682. doi: 10.1126/sciadv.1701682, PMID: 29109977 PMC5665598 · DOI
  38. Guastella A. J. Ward P. B. Hickie I. B. Shahrestani S. Hodge M. A. Scott E. M.. (2015). A single dose of oxytocin nasal spray improves higher-order social cognition in schizophrenia. Schizophr. Res. 168, 628– 633. doi: 10.1016/j.schres.2015.06.005, PMID: 26150070 · DOI
  39. Gucek A. Gandasi N. R. Omar-Hmeadi M. Bakke M. Doskeland S. O. Tengholm A.. (2019). Fusion pore regulation by cAMP/Epac2 controls cargo release during insulin exocytosis. elife 8: e41711. doi: 10.7554/eLife.41711, PMID: 31099751 PMC6557626 · DOI
  40. Hayden M. R. Banks W. A. (2021). Deficient leptin cellular signaling plays a key role in brain ultrastructural remodeling in obesity and type 2 diabetes mellitus. Int. J. Mol. Sci. 22: 5427. doi: 10.3390/ijms22115427, PMID: 34063911 PMC8196569 · DOI
  41. He K. Nie L. Ali T. Wang S. Chen X. Liu Z.. (2021). Adiponectin alleviated Alzheimer-like pathologies via autophagy-lysosomal activation. Aging Cell 20: e13514. doi: 10.1111/acel.13514, PMID: 34775673 PMC8672778 · DOI
  42. Hewitt S. C. Wu S. P. Wang T. Young S. L. Spencer T. E. DeMayo F. J. (2022). Progesterone signaling in endometrial epithelial organoids. Cells 11: 1760. doi: 10.3390/cells11111760, PMID: 35681455 PMC9179553 · DOI
  43. Heymann D. Stern Y. Cosentino S. Tatarina-Nulman O. Dorrejo J. N. Gu Y. (2016). The association between alcohol use and the progression of Alzheimer's disease. Curr. Alzheimer Res. 13, 1356– 1362. doi: 10.2174/1567205013666160603005035, PMID: 27628432 PMC5526221 · DOI
  44. Holscher C. (2022). Protective properties of GLP-1 and associated peptide hormones in neurodegenerative disorders. Br. J. Pharmacol. 179, 695– 714. doi: 10.1111/bph.15508, PMID: 33900631 PMC8820183 · DOI
  45. Huang C. Gan D. Fan C. Wen C. Li A. Li Q.. (2018). The secretion from neural stem cells pretreated with lycopene protects against tert-butyl Hydroperoxide-induced neuron oxidative damage. Oxidative Med. Cell. Longev. 2018: 5490218. doi: 10.1155/2018/5490218, PMID: 30140366 PMC6081585 · DOI
  46. Huo X. Wang L. Shao J. Zhou C. Ying X. Zhao J.. (2022). LINC00667 regulates MPP(+) -induced neuronal injury in Parkinson's disease. Ann. Clin. Transl. Neurol. 9, 707– 721. doi: 10.1002/acn3.51480, PMID: 35426258 PMC9082386 · DOI
  47. Ikarashi M. Tsuchida J. Nagahashi M. Takeuchi S. Moro K. Toshikawa C.. (2021). Plasma Sphingosine-1-phosphate levels are associated with progression of estrogen receptor-positive breast cancer. Int. J. Mol. Sci. 22: 13367. doi: 10.3390/ijms222413367, PMID: 34948163 PMC8703495 · DOI
  48. Kamal H. Tan G. C. Ibrahim S. F. Shaikh M. F. Mohamed I. N. Mohamed R. M. P.. (2020). Alcohol use disorder, neurodegeneration, Alzheimer's and Parkinson's disease: interplay between oxidative stress, Neuroimmune response and excitotoxicity. Front. Cell. Neurosci. 14: 282. doi: 10.3389/fncel.2020.00282, PMID: 33061892 PMC7488355 · DOI
  49. Kautzky-Willer A. Harreiter J. Pacini G. (2016). Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr. Rev. 37, 278– 316. doi: 10.1210/er.2015-1137, PMID: 27159875 PMC4890267 · DOI · Paper page
  50. Kim H. Yoo J. Han K. Lee D. Y. Fava M. Mischoulon D.. (2022). Hormone therapy and the decreased risk of dementia in women with depression: a population-based cohort study. Alzheimers Res. Ther. 14: 83. doi: 10.1186/s13195-022-01026-3, PMID: 35710453 PMC9202170 · DOI
  51. Kiran S. Rakib A. Kodidela S. Kumar S. Singh U. P. (2022). High-fat diet-induced dysregulation of immune cells correlates with macrophage phenotypes and chronic inflammation in adipose tissue. Cells 11: 1327. doi: 10.3390/cells11081327, PMID: 35456006 PMC9031506 · DOI
  52. Kitaguchi T. Oya M. Wada Y. Tsuboi T. Miyawaki A. (2013). Extracellular calcium influx activates adenylate cyclase 1 and potentiates insulin secretion in MIN6 cells. Biochem. J. 450, 365– 373. doi: 10.1042/BJ20121022, PMID: 23282092 · DOI
  53. Kobayashi T. Imachi H. Fukunaga K. Lyu J. Sato S. Saheki T.. (2022). HDL promotes adiponectin gene expression via the CAMKK/CAMKIV pathway. J. Mol. Endocrinol. 68, 89– 98. doi: 10.1530/JME-20-0211, PMID: 34845988 · DOI
  54. Kumar S. Reddy A. P. Yin X. Reddy P. H. (2019). Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's disease. Biochim. Biophys. Acta Mol. basis Dis. 1865, 2428– 2440. doi: 10.1016/j.bbadis.2019.06.006, PMID: 31181293 PMC6688505 · DOI
  55. Letenneur L. Gilleron V. Commenges D. Helmer C. Orgogozo J. M. Dartigues J. F. (1999). Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project. J. Neurol. Neurosurg. Psychiatry 66, 177– 183. doi: 10.1136/jnnp.66.2.177, PMID: 10071096 PMC1736218 · DOI · Paper page
  56. Li H. D. Funk C. C. McFarland K. Dammer E. B. Allen M. Carrasquillo M. M.. (2021). Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease. Alzheimers Dement. 17, 984– 1004. doi: 10.1002/alz.12254, PMID: 33480174 PMC8248162 · DOI
  57. Lu J. Zhang Y. Wang Y. Z. Li Y. Y. Wang R. Zhong Y. J.. (2022). Caffeic acid dimethyl ether alleviates alcohol-induced hepatic steatosis via microRNA-378b-mediated CaMKK2-AMPK pathway. Bioengineered 13, 11123– 11137. doi: 10.1080/21655979.2022.2060586, PMID: 35481488 PMC9208468 · DOI
  58. Luine V. N. (2014). Estradiol and cognitive function: past, present and future. Horm. Behav. 66, 602– 618. doi: 10.1016/j.yhbeh.2014.08.011, PMID: 25205317 PMC4318702 · DOI · Paper page
  59. Lyra A. Ferreira F. R. Moises R. C. S. de Noronha R. M. Calliari L. E. (2022). The role of intermittent continuous glucose monitoring in a successful outpatient transition from insulin to glibenclamide in a patient with transient neonatal diabetes. Arch. Endocrinol. Metab. doi: 10.20945/2359-3997000000484, PMID: 35612844 PMC9832861 · DOI
  60. Ma C. Li S. Hu Y. Ma Y. Wu Y. Wu C.. (2021). AIM2 controls microglial inflammation to prevent experimental autoimmune encephalomyelitis. J. Exp. Med. 218: e20201796. doi: 10.1084/jem.20201796, PMID: 33710283 PMC7961553 · DOI
  61. Ma Z. Wang C. Bai X. Wang L. Wu Q. Cai Z.. (2022). TCF7 is highly expressed in immune cells on the atherosclerotic plaques, and regulating inflammatory signaling via NFkappaB/AKT/STAT1 signaling. Biosci. Rep. 42: BSR20212064. doi: 10.1042/BSR20212064, PMID: 35792753 PMC9297684 · DOI
  62. Maciel N. I. G. Filiu-Braga L. D. C. Neves F. A. R. Rego E. M. Lucena-Araujo A. R. Saldanha-Araujo F. (2021). Low expression of ZHX1 and ZHX2 impacts on the prognosis of chronic lymphocytic leukemia. Biomark. Res. 9: 10. doi: 10.1186/s40364-021-00263-2, PMID: 33541423 PMC7863484 · DOI
  63. Mairet-Coello G. Courchet J. Pieraut S. Courchet V. Maximov A. Polleux F. (2013). The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Abeta oligomers through tau phosphorylation. Neuron 78, 94– 108. doi: 10.1016/j.neuron.2013.02.003, PMID: 23583109 PMC3784324 · DOI · Paper page
  64. Manczak M. Kandimalla R. Fry D. Sesaki H. Reddy P. H. (2016). Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease. Hum. Mol. Genet. 25, 5148– 5166. doi: 10.1093/hmg/ddw330, PMID: 27677309 PMC6078633 · DOI
  65. Mashock M. J. Zanon T. Kappell A. D. Petrella L. N. Andersen E. C. Hristova K. R. (2016). Copper oxide nanoparticles impact several toxicological endpoints and cause neurodegeneration in Caenorhabditis elegans. PLoS One 11: e0167613. doi: 10.1371/journal.pone.0167613, PMID: 27911941 PMC5135131 · DOI
  66. Mattar J. M. Majchrzak M. Iannucci J. Bartman S. Robinson J. K. Grammas P. (2022). Sex differences in metabolic indices and chronic Neuroinflammation in response to prolonged high-fat diet in ApoE4 Knock-in mice. Int. J. Mol. Sci. 23: 3921. doi: 10.3390/ijms23073921, PMID: 35409283 PMC8999114 · DOI
  67. Matyi J. M. Rattinger G. B. Schwartz S. Buhusi M. Tschanz J. T. (2019). Lifetime estrogen exposure and cognition in late life: the Cache County study. Menopause 26, 1366– 1374. doi: 10.1097/GME.0000000000001405, PMID: 31613825 PMC7448538 · DOI
  68. Mehla J. Singh I. Diwan D. Nelson J. W. Lawrence M. Lee E.. (2021). STAT3 inhibitor mitigates cerebral amyloid angiopathy and parenchymal amyloid plaques while improving cognitive functions and brain networks. Acta Neuropathol. Commun. 9: 193. doi: 10.1186/s40478-021-01293-5, PMID: 34911575 PMC8672532 · DOI
  69. Mehta M. Adem A. Kahlon M. S. Sabbagh M. N. (2012). The nicotinic acetylcholine receptor: smoking and Alzheimer's disease revisited. Front. Biosci. 4, 169– 180. doi: 10.2741/367, PMID: 22201862 PMC5502782 · DOI
  70. Mielke M. M. Aggarwal N. T. Vila-Castelar C. Agarwal P. Arenaza-Urquijo E. M. Brett B.. (2022). Consideration of sex and gender in Alzheimer's disease and related disorders from a global perspective. Alzheimers Dement. doi: 10.1002/alz.12662, PMID: 35394117 PMC9547039 · DOI · Paper page
  71. Moreno-Gonzalez I. Estrada L. D. Sanchez-Mejias E. Soto C. (2013). Smoking exacerbates amyloid pathology in a mouse model of Alzheimer's disease. Nat. Commun. 4: 1495. doi: 10.1038/ncomms2494 23422663 · DOI
  72. Nordstrom A. Hadrevi J. Olsson T. Franks P. W. Nordstrom P. (2016). Higher prevalence of type 2 diabetes in men than in women is associated with differences in visceral fat mass. J. Clin. Endocrinol. Metab. 101, 3740– 3746. doi: 10.1210/jc.2016-1915, PMID: 27490920 · DOI
  73. Oh-Hashi K. Yamamoto A. Murase R. Hirata Y. (2021). Comparative analysis of CREB3 and CREB3L2 protein expression in HEK293 cells. Int. J. Mol. Sci. 22: 2767. doi: 10.3390/ijms22052767, PMID: 33803345 PMC7967177 · DOI
  74. Opazo-Rios L. Soto-Catalan M. Lazaro I. Sala-Vila A. Jimenez-Castilla L. Orejudo M.. (2022). Meta-inflammation and De novo lipogenesis markers are involved in metabolic associated fatty liver disease progression in BTBR Ob/Ob mice. Int. J. Mol. Sci. 23: 3965. doi: 10.3390/ijms23073965, PMID: 35409324 PMC8999923 · DOI
  75. Paci P. Colombo T. Fiscon G. Gurtner A. Pavesi G. Farina L. (2017). SWIM: a computational tool to unveiling crucial nodes in complex biological networks. Sci. Rep. 7: 44797. doi: 10.1038/srep44797, PMID: 28317894 PMC5357943 · DOI
  76. Paci P. Fiscon G. Conte F. Licursi V. Morrow J. Hersh C.. (2020). Integrated transcriptomic correlation network analysis identifies COPD molecular determinants. Sci. Rep. 10: 3361. doi: 10.1038/s41598-020-60228-7, PMID: 32099002 PMC7042269 · DOI
  77. Patel H. Hodges A. K. Curtis C. Lee S. H. Troakes C. Dobson R. J. B.. (2019). Transcriptomic analysis of probable asymptomatic and symptomatic alzheimer brains. Brain Behav. Immun. 80, 644– 656. doi: 10.1016/j.bbi.2019.05.009, PMID: 31063847 · DOI
  78. Peters R. Ee N. Peters J. Booth A. Mudway I. Anstey K. J. (2019). Air pollution and dementia: a systematic review. J. Alzheimers Dis. 70, S145– S163. doi: 10.3233/JAD-180631, PMID: 30775976 PMC6700631 · DOI · Paper page
  79. Potashkin J. A. Bottero V. Santiago J. A. Quinn J. P. (2019). Computational identification of key genes that may regulate gene expression reprogramming in Alzheimer's patients. PLoS One 14: e0222921. doi: 10.1371/journal.pone.0222921, PMID: 31545826 PMC6756555 · DOI
  80. Potashkin J. A. Bottero V. Santiago J. A. Quinn J. P. (2020). Bioinformatic analysis reveals phosphodiesterase 4D-interacting protein as a key frontal cortex dementia switch gene. Int. J. Mol. Sci. 21: 3787. doi: 10.3390/ijms21113787, PMID: 32471155 PMC7313474 · DOI
  81. Qiu T. Xie F. Zeng Q. Shen Z. Du G. Xu X.. (2022). Interactions between cigarette smoking and cognitive status on functional connectivity of the cortico-striatal circuits in individuals without dementia: a resting-state functional MRI study. CNS Neurosci. Ther. 28, 1195– 1204. doi: 10.1111/cns.13852, PMID: 35506354 PMC9253779 · DOI
  82. Ragancokova D. Rocca E. Oonk A. M. Schulz H. Rohde E. Bednarsch J.. (2014). TSHZ1-dependent gene regulation is essential for olfactory bulb development and olfaction. J. Clin. Invest. 124, 1214– 1227. doi: 10.1172/JCI72466, PMID: 24487590 PMC3934178 · DOI
  83. Rajan K. B. Weuve J. Barnes L. L. McAninch E. A. Wilson R. S. Evans D. A. (2021). Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020-2060). Alzheimers Dement. 17, 1966– 1975. doi: 10.1002/alz.12362, PMID: 34043283 PMC9013315 · DOI · Paper page
  84. Raum J. C. Soleimanpour S. A. Groff D. N. Core N. Fasano L. Garratt A. N.. (2015). Tshz1 regulates pancreatic beta-cell maturation. Diabetes 64, 2905– 2914. doi: 10.2337/db14-1443, PMID: 25918232 PMC4512227 · DOI
  85. Reyes Diaz J. V. Jin Y. Garber K. Cossen K. M. Li Y. Jin P.. (2022). A homozygous exonic variant leading to exon skipping in ABCC8 as the cause of severe congenital hyperinsulinism. Am. J. Med. Genet. A 188, 2429– 2433. doi: 10.1002/ajmg.a.62843, PMID: 35621279 · DOI
  86. Robinson A. Lubitz I. Atrakchi-Baranes D. Licht-Murava A. Katsel P. Leroith D.. (2019). Combination of insulin with a GLP1 agonist is associated with better memory and Normal expression of insulin receptor pathway genes in a mouse model of Alzheimer's disease. J. Mol. Neurosci. 67, 504– 510. doi: 10.1007/s12031-019-1257-9, PMID: 30635783 PMC6549496 · DOI
  87. Rodrigue K. M. Kennedy K. M. Park D. C. (2009). Beta-amyloid deposition and the aging brain. Neuropsychol. Rev. 19, 436– 450. doi: 10.1007/s11065-009-9118-x, PMID: 19908146 PMC2844114 · DOI · Paper page
  88. Ruitenberg A. Ott A. van Swieten J. C. Hofman A. Breteler M. M. (2001). Incidence of dementia: does gender make a difference? Neurobiol. Aging 22, 575– 580. doi: 10.1016/s0197-4580(01)00231-7 11445258 · DOI · Paper page
  89. Rusanen M. Kivipelto M. Quesenberry C. P. Jr. Zhou J. Whitmer R. A. (2011). Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. Arch. Intern. Med. 171, 333– 339. doi: 10.1001/archinternmed.2010.393, PMID: 20975015 · DOI
  90. Salarinasab S. Nourazarian A. Nikanfar M. Abdyazdani N. Kazemi M. Feizy N.. (2017). Impact of morphine on the expression of insulin receptor and protein levels of insulin/IGFs in rat neural stem cells. Neurosci. Lett. 660, 147– 154. doi: 10.1016/j.neulet.2017.09.035, PMID: 28923480 · DOI
  91. Salarinasab S. Salimi L. Alidadiani N. Shokrollahi E. Arzhanga P. Karbasforush S.. (2020). Interaction of opioid with insulin/IGFs signaling in Alzheimer's disease. J. Mol. Neurosci. 70, 819– 834. doi: 10.1007/s12031-020-01478-y, PMID: 32026387 · DOI
  92. Sampieri L. Funes Chaban M. Di Giusto P. Rozes-Salvador V. Alvarez C. (2021). CREB3L2 modulates nerve growth factor-induced cell differentiation. Front. Mol. Neurosci. 14: 650338. doi: 10.3389/fnmol.2021.650338, PMID: 34421533 PMC8370844 · DOI
  93. Santiago J. A. Bottero V. Potashkin J. A. (2019). Transcriptomic and network analysis highlight the Association of Diabetes at different stages of Alzheimer's disease. Front. Neurosci. 13: 1273. doi: 10.3389/fnins.2019.01273, PMID: 31849586 PMC6895844 · DOI
  94. Santiago J. A. Potashkin J. A. (2021). The impact of disease comorbidities in Alzheimer's disease. Front. Aging Neurosci. 13: 631770. doi: 10.3389/fnagi.2021.631770, PMID: 33643025 PMC7906983 · DOI · Paper page
  95. Santiago J. A. Quinn J. P. Potashkin J. A. (2021). Network analysis identifies sex-specific gene expression changes in blood of amyotrophic lateral sclerosis patients. Int. J. Mol. Sci. 22: 7150. doi: 10.3390/ijms22137150, PMID: 34281203 PMC8269377 · DOI
  96. Santiago J. A. Quinn J. P. Potashkin J. A. (2022). Physical activity rewires the human brain against neurodegeneration. Int. J. Mol. Sci. 23: 6223. doi: 10.3390/ijms23116223, PMID: 35682902 PMC9181322 · DOI
  97. Sharma M. Dey C. S. (2021). Role of Akt isoforms in neuronal insulin signaling and resistance. Cell. Mol. Life Sci. 78, 7873– 7898. doi: 10.1007/s00018-021-03993-6, PMID: 34724097 PMC11073101 · DOI
  98. Shumaker S. A. Legault C. Kuller L. Rapp S. R. Thal L. Lane D. S. (et al., 2004). Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative memory study. JAMA 291, 2947– 2958. doi: 10.1001/jama.291.24.2947, PMID: 15213206 · DOI
  99. Siegmund K. D. Connor C. M. Campan M. Long T. I. Weisenberger D. J. Biniszkiewicz D.. (2007). DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS One 2: e895. doi: 10.1371/journal.pone.0000895, PMID: 17878930 PMC1964879 · DOI
  100. Siu M. K. Chen W. Y. Tsai H. Y. Chen H. Y. Yin J. J. Chen C. L.. (2017). TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer. Prostate Cancer Prostatic Dis. 20, 172– 178. doi: 10.1038/pcan.2017.2, PMID: 28220803 · DOI
  101. Smith B. S. Diaguarachchige De Silva K. H. Hashemi A. Duncan R. E. Grapentine S. Bakovic M.. (2022). Transcription factor CREB3 is a potent regulator of high-fat diet-induced obesity and energy metabolism. Int. J. Obes. 46, 1446– 1455. doi: 10.1038/s41366-022-01128-w, PMID: 35637262 · DOI
  102. Sundararajan T. Manzardo A. M. Butler M. G. (2018). Functional analysis of schizophrenia genes using GeneAnalytics program and integrated databases. Gene 641, 25– 34. doi: 10.1016/j.gene.2017.10.035, PMID: 29032150 PMC6706854 · DOI
  103. Syeda T. Cannon J. R. (2022). Potential role of heterocyclic aromatic amines in neurodegeneration. Chem. Res. Toxicol. 35, 59– 72. doi: 10.1021/acs.chemrestox.1c00274, PMID: 34990108 PMC10443083 · DOI
  104. Taipale H. Hamina A. Lampela P. Tanskanen A. Tiihonen J. Karttunen N.. (2018). Is Alzheimer's disease associated with previous opioid use? Pain Med. 19, 2115– 2121. doi: 10.1093/pm/pnx210, PMID: 29025166 · DOI
  105. Van de Velde M. E. van den Berg M. H. Kaspers G. J. L. Abbink F. C. H. Twisk J. W. R. van der Sluis I. M.. (2021). The association between vincristine-induced peripheral neuropathy and health-related quality of life in children with cancer. Cancer Med. 10, 8172– 8181. doi: 10.1002/cam4.4289, PMID: 34725942 PMC8607258 · DOI
  106. Van Duijn C. M. Hofman A. (1991). Relation between nicotine intake and Alzheimer's disease. BMJ 302, 1491– 1494. doi: 10.1136/bmj.302.6791.1491, PMID: 1855016 PMC1670208 · DOI
  107. Wan H. L. Hong X. Y. Zhao Z. H. Li T. Zhang B. G. Liu Q.. (2021). STAT3 ameliorates cognitive deficits via regulation of NMDAR expression in an Alzheimer's disease animal model. Theranostics 11, 5511– 5524. doi: 10.7150/thno.56541, PMID: 33859760 PMC8039956 · DOI
  108. Wang Z. T. Li K. Y. Tan C. C. Xu W. Shen X. N. Cao X. P.. (2021). Associations of alcohol consumption with cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact older adults: the CABLE study. J. Alzheimers Dis. 82, 1045– 1054. doi: 10.3233/JAD-210140, PMID: 34151793 · DOI
  109. Wang X. She H. Mao Z. (2009). Phosphorylation of neuronal survival factor MEF2D by glycogen synthase kinase 3beta in neuronal apoptosis. J. Biol. Chem. 284, 32619– 32626. doi: 10.1074/jbc.M109.067785, PMID: 19801631 PMC2781676 · DOI
  110. Wang T. Yuan F. Chen Z. Zhu S. Chang Z. Yang W.. (2020). Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson's disease patients with type 2 diabetes mellitus. Aging 12, 15682– 15704. doi: 10.18632/aging.103776, PMID: 32805719 PMC7467390 · DOI
  111. Wild S. Roglic G. Green A. Sicree R. King H. (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047– 1053. doi: 10.2337/diacare.27.5.1047 15111519 · DOI · Paper page
  112. Xia J. Benner M. J. Hancock R. E. (2014). NetworkAnalyst--integrative approaches for protein-protein interaction network analysis and visual exploration. Nucleic Acids Res. 42, W167– W174. doi: 10.1093/nar/gku443, PMID: 24861621 PMC4086107 · DOI
  113. Xiong J. Kang S. S. Wang Z. Liu X. Kuo T. C. Korkmaz F.. (2022). FSH blockade improves cognition in mice with Alzheimer's disease. Nature 603, 470– 476. doi: 10.1038/s41586-022-04463-0, PMID: 35236988 PMC9940301 · DOI · Paper page
  114. Xu Y. Kong J. Hu P. (2021). Computational drug repurposing for Alzheimer's disease using risk genes from GWAS and single-cell RNA sequencing studies. Front. Pharmacol. 12: 617537. doi: 10.3389/fphar.2021.617537, PMID: 34276354 PMC8277916 · DOI
  115. Xu S. Koo J. W. Kang U. G. (2021). Comparison of the sensitizing effects of cocaine and ethanol on histone deacetylase isoforms in the rat brain. Neuroreport 32, 423– 430. doi: 10.1097/WNR.0000000000001587, PMID: 33788811 · DOI
  116. Yang M. T. Chang W. H. Kuo T. F. Shen M. Y. Yang C. W. Tien Y. J.. (2021). Identification of novel biomarkers for pre-diabetic diagnosis using a combinational approach. Front. Endocrinol. 12: 641336. doi: 10.3389/fendo.2021.641336, PMID: 33995275 PMC8113970 · DOI
  117. Yang J. J. Keohane L. M. Pan X. Qu R. Shu X. O. Lipworth L. P.. (2022). Association of Healthy Lifestyles with risk of Alzheimer disease and related dementias in low-income black and White Americans. Neurology 99, e944– e953. doi: 10.1212/WNL.0000000000200774, PMID: 35697505 PMC9502739 · DOI · Paper page
  118. Yao M. Li L. Huang M. Tan Y. Shang Y. Meng X.. (2021). Sanye tablet ameliorates insulin resistance and dysregulated lipid metabolism in high-fat diet-induced obese mice. Front. Pharmacol. 12: 713750. doi: 10.3389/fphar.2021.713750, PMID: 34658856 PMC8511530 · DOI
  119. You Y. Bai F. Li H. Ma Y. Yao L. Hu J.. (2020). Prognostic value and therapeutic implications of ZHX family member expression in human gastric cancer. Am. J. Transl. Res. 12, 3376– 3388. 32774706 PMC7407748
  120. Zamani M. R. Allen Y. S. Owen G. P. Gray J. A. (1997). Nicotine modulates the neurotoxic effect of beta-amyloid protein 25-35 in hippocampal cultures. Neuroreport 8, 513– 517. doi: 10.1097/00001756-199701200-00027, PMID: 9080439 · DOI
  121. Zandi P. P. Carlson M. C. Plassman B. L. Welsh-Bohmer K. A. Mayer L. S. Steffens D. C.. (2002). Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County study. JAMA 288, 2123– 2129. doi: 10.1001/jama.288.17.2123, PMID: 12413371 · DOI
  122. Zhang J. Gao Y. Zhang L. Zhang C. Zhao Y. Zhang Y.. (2022). Alpha-lipoic acid attenuates MPTP/MPP(+)-induced neurotoxicity: roles of SIRT1-dependent PGC-1alpha signaling pathways. Neurotox. Res. 40, 410– 419. doi: 10.1007/s12640-022-00479-6, PMID: 35146598 · DOI
  123. Zhang Y. Hu S. Huang H. Liu J. (2022). A case report of maturity-onset diabetes of the young 12: large fragment deletion in ABCC8 gene with literature review. Ann. Transl. Med. 10: 378. doi: 10.21037/atm-22-807, PMID: 35434002 PMC9011213 · DOI
  124. Zhang Y. Xu N. Ding Y. Doycheva D. M. Zhang Y. Li Q.. (2019). Chemerin reverses neurological impairments and ameliorates neuronal apoptosis through ChemR23/CAMKK2/AMPK pathway in neonatal hypoxic-ischemic encephalopathy. Cell Death Dis. 10: 97. doi: 10.1038/s41419-019-1374-y, PMID: 30718467 PMC6362229 · DOI
  125. Zhang Y. Xu N. Ding Y. Zhang Y. Li Q. Flores J.. (2018). Chemerin suppresses neuroinflammation and improves neurological recovery via CaMKK2/AMPK/Nrf2 pathway after germinal matrix hemorrhage in neonatal rats. Brain Behav. Immun. 70, 179– 193. doi: 10.1016/j.bbi.2018.02.015, PMID: 29499303 PMC5953818 · DOI
  126. Zhornitsky S. Chaudhary S. Le T. M. Chen Y. Zhang S. Potvin S.. (2021). Cognitive dysfunction and cerebral volumetric deficits in individuals with Alzheimer's disease, alcohol use disorder, and dual diagnosis. Psychiatry Res. Neuroimaging 317: 111380. doi: 10.1016/j.pscychresns.2021.111380, PMID: 34482052 PMC8579376 · DOI
  127. Zhou S. Wang K. (2021). Childhood secondhand smoke exposure and risk of dementia, Alzheimer's disease and stroke in adulthood: a prospective cohort study. J. Prev Alzheimers Dis. 8, 345– 350. doi: 10.14283/jpad.2021.10, PMID: 34101793 · DOI
  128. Zhu M. Jia L. Li F. Jia J. (2020). Identification of KIAA0513 and other hub genes associated with Alzheimer disease using weighted gene Coexpression network analysis. Front. Genet. 11: 981. doi: 10.3389/fgene.2020.00981, PMID: 33005179 PMC7483929 · DOI
  129. Zummo F. P. Krishnanda S. I. Georgiou M. O'Harte F. P. Parthsarathy V. Cullen K. S.. (2022). Exendin-4 stimulates autophagy in pancreatic beta-cells via the RAPGEF/EPAC-ca(2+)-PPP3/calcineurin-TFEB axis. Autophagy 18, 799– 815. doi: 10.1080/15548627.2021.1956123, PMID: 34338148 PMC9037459 · DOI

Authors
Santiago, J. A., Quinn, J. P., & Potashkin, J. A.
Affiliations
Rosalind Franklin University of Medicine and Science (US)
Corresponding author
Potashkin, Judith A.
Venue
Frontiers in Aging Neuroscience
Published
2022-10-31
Volume
14
Pages
1009368-1009368
ISSN
1663-4365 (ISSN-L)
OpenAlex
W4307870447
Cited by
16
References
143
Citations by year
2026: 6 · 2025: 2 · 2024: 6 · 2023: 2
FWCI
1.55
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Aging Neuroscience (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institute on Aging (R01AG062176)
  • Rosalind Franklin University of Medicine and Science
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, sex differences, sex-specific gene expression, entorhinal cortex, switch genes, co-expression network analysis, asymptomatic Alzheimer's disease, morphine addiction, retrograde endocannabinoid signaling, autophagy, nicotine dependence, oxytocin signaling, insulin signaling, PI3K/Akt signaling, endocytosis, neurotoxicants, cognitive resilience

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review